These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 29497966)
1. Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons. Turner EA; Atigh MK; Erwin MM; Christians U; Yazdani SK Cardiovasc Eng Technol; 2018 Jun; 9(2):240-250. PubMed ID: 29497966 [TBL] [Abstract][Full Text] [Related]
2. In vitro particulate and in vivo drug retention study of a novel polyethylene oxide formulation for drug-coated balloons. Anderson JA; Lamichhane S; Vierhout T; Sherman A; Engebretson D; Pohlson K; Remund T; Kelly P J Vasc Surg; 2018 May; 67(5):1537-1545.e7. PubMed ID: 28843789 [TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons. Kempin W; Kaule S; Reske T; Grabow N; Petersen S; Nagel S; Schmitz KP; Weitschies W; Seidlitz A Eur J Pharm Biopharm; 2015 Oct; 96():322-8. PubMed ID: 26318979 [TBL] [Abstract][Full Text] [Related]
4. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies. Krishnan P; Faries P; Niazi K; Jain A; Sachar R; Bachinsky WB; Cardenas J; Werner M; Brodmann M; Mustapha JA; Mena-Hurtado C; Jaff MR; Holden AH; Lyden SP Circulation; 2017 Sep; 136(12):1102-1113. PubMed ID: 28729250 [TBL] [Abstract][Full Text] [Related]
5. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients. Radke PW; Joner M; Joost A; Byrne RA; Hartwig S; Bayer G; Steigerwald K; Wittchow E EuroIntervention; 2011 Oct; 7(6):730-7. PubMed ID: 21986331 [TBL] [Abstract][Full Text] [Related]
6. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model. Yazdani SK; Pacheco E; Nakano M; Otsuka F; Naisbitt S; Kolodgie FD; Ladich E; Rousselle S; Virmani R Catheter Cardiovasc Interv; 2014 Jan; 83(1):132-40. PubMed ID: 23703778 [TBL] [Abstract][Full Text] [Related]
7. Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons. Goel E; Erwin M; Cawthon CV; Schaff C; Fedor N; Rayl T; Wilson O; Christians U; Register TC; Geary RL; Saul J; Yazdani SK Molecules; 2020 Mar; 25(7):. PubMed ID: 32244375 [TBL] [Abstract][Full Text] [Related]
8. Development of drug-coated balloon for the treatment of multiple peripheral artery segments. Anderson JA; Lamichhane S; Fuglsby K; Remund T; Pohlson K; Evans R; Engebretson D; Kelly P J Vasc Surg; 2020 May; 71(5):1750-1757.e7. PubMed ID: 31519510 [TBL] [Abstract][Full Text] [Related]
9. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine. Buszman PP; Milewski K; Zurakowski A; Pajak J; Jelonek M; Gasior P; Peppas A; Tellez A; Granada JF; Buszman PE Catheter Cardiovasc Interv; 2014 Feb; 83(2):325-33. PubMed ID: 23703720 [TBL] [Abstract][Full Text] [Related]
10. Development of an automated micropipette coating method for drug-coated balloons. Fuglsby K; Anderson JA; Engebretson D; Lamichhane S J Biomed Mater Res B Appl Biomater; 2020 Jul; 108(5):2258-2275. PubMed ID: 31967398 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Evaluation of Two Paclitaxel-Coated Balloons with Different Drug Load in a Short-Term Porcine Study. Abadal JM; Vazquez E; Morales M; Toro A; Quintana M; Araujo M Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1152-8. PubMed ID: 27094691 [TBL] [Abstract][Full Text] [Related]
12. Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model. Buszman PP; Tellez A; Afari ME; Peppas A; Conditt GB; Rousselle SD; McGregor JC; Stenoien M; Kaluza GL; Granada JF JACC Cardiovasc Interv; 2013 Aug; 6(8):883-90. PubMed ID: 23968706 [TBL] [Abstract][Full Text] [Related]
13. Ultrasound controlled paclitaxel releasing system-A novel method for improving the availability of coronary artery drug coated balloon. Song C; Zhou C; Zhang J; Feng X; Cui X; Zhang F; Ma J; Toft ES; Ge J; Zhang H Catheter Cardiovasc Interv; 2020 Aug; 96(2):E119-E128. PubMed ID: 31659805 [TBL] [Abstract][Full Text] [Related]
14. Turner E; Erwin M; Atigh M; Christians U; Saul JM; Yazdani SK Front Pharmacol; 2018; 9():808. PubMed ID: 30104972 [No Abstract] [Full Text] [Related]
15. Understanding the Mechanism of Drug Transfer and Retention of Drug-Coated Balloons. Villar-Matamoros E; Stokes L; Lloret A; Todd M; Tillman BW; Yazdani SK J Cardiovasc Pharmacol Ther; 2022; 27():10742484221119559. PubMed ID: 35972237 [TBL] [Abstract][Full Text] [Related]
16. Optimization of balloon coating process for paclitaxel coated balloons via micro-pipetting method. Woolford SE; Tran M; NguyenPho A; McDermott MK; Oktem B; Wickramasekara S Int J Pharm; 2019 Jan; 554():312-321. PubMed ID: 30395954 [TBL] [Abstract][Full Text] [Related]